IDP-73152

derivative of aminopiperidine and peptide deformylase (PDF) inhibitor for the treatment of complicated bacterial skin and respiratory tract infections

Also Known As:

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	An, Kyung-Mi: 2 articles (05/2022 - 01/2019)
2.	Chung, Suk-Jae: 2 articles (05/2022 - 10/2017)
3.	Lee, Myongjae: 2 articles (05/2022 - 10/2017)
4.	Lee, Hong-Sub: 2 articles (01/2019 - 10/2017)
5.	Jeong, Yoo-Seong: 1 article (05/2022)
6.	Kim, Min-Soo: 1 article (05/2022)
7.	Jung, Juyoung: 1 article (01/2019)
8.	Lee, MyongJae: 1 article (01/2019)
9.	Park, Sang-In: 1 article (01/2019)
10.	Shin, Dongseong: 1 article (01/2019)

Related Diseases

1.	Respiratory Tract Infections (Respiratory Tract Infection) 01/01/2019 - "IDP-73152 mesylate is a peptide deformylase inhibitor under investigation for the treatment of complicated skin and respiratory tract infections. "
2.	Infections 10/25/2017 - "IDP-73152, a novel inhibitor of a bacterial peptide deformylase, was recently approved as a new, investigational drug in Korea for the clinical management of infections caused by Gram positive bacteria. "
3.	Communicable Diseases (Infectious Diseases) 05/28/2022 - "This model may be useful in predicting efficacious doses of IDP-73152 for the management of infectious disease in humans."

Related Drugs and Biologics

1.	peptide deformylase
2.	Investigational Drugs